Latest News about BNTX
Recent news which mentions BNTX
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
COVID boosters that target dominant omicron strains set to start in coming days after CDC gives its OK
September 02, 2022
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
From Benzinga
Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster
September 01, 2022
From MarketWatch
2 Big Red Flags and 1 Small Green Flag For Pfizer Stock
September 01, 2022
From Motley Fool
From Benzinga
Why Novavax Stock Got Pummeled Today
August 31, 2022
From Motley Fool
Why Moderna Stock Slumped on Wednesday
August 31, 2022
From Motley Fool
From Benzinga
U.S. life expectancy saw the biggest two-year decline during COVID in almost a century, report finds
August 31, 2022
From MarketWatch
Should Pfizer Investors Be Worried About Moderna's Lawsuits?
August 31, 2022
From Motley Fool
From Benzinga
After Double-Digit Percentage Declines, Are Vaccine Stocks Buys?
August 30, 2022
From Motley Fool
US Stock Futures Higher Ahead Of Economic Data, Fed Speakers
August 30, 2022
From Benzinga
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
August 30, 2022
From Benzinga
Could This Move by Moderna Cost Pfizer Billions?
August 28, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
August 26, 2022
From MarketWatch
From Benzinga
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
From Benzinga
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
August 24, 2022
From MarketWatch
Here's Why This Dominant Income Stock Is a Buy
August 24, 2022
From Motley Fool
From MarketWatch
Pfizer and BioNTech say data shows COVID vaccine has more than 70% efficacy in small children, and cases now rising in just 7 states
August 23, 2022
From MarketWatch
Pfizer/BioNTech's COVID-19 Vaccine Updated Data Shows Around 76% Efficacy In Toddlers
August 23, 2022
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 22, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.